Skip to main content

Pharma News

Pharma Courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Researcher finds death reduction for molnupiravir and nirmatrelvir–ritonavir users with COVID-19

    A research team comprised of members from the Department of Pharmacology and Pharmacy, School of Public Health, Department of Family Medicine and Primary Care, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong (HKUMed), and Laboratory of Data Discovery for Health (D²4H) have conducted one of the first real-world studies to explore the inpatient use of oral antivirals during a pandemic wave dominated by the SARS-CoV-2 omicron variant.

  • Hormone protects against development of fatty liver

    A study group at MedUni Vienna has identified a regulatory loop controlled by leptin, by which this adipocyte-derived hormone regulates hepatic lipid metabolism via the autonomic nervous system. The study provides evidence that this adipose tissue-brain-liver axis, previously identified in animal models, also exists in humans and is opening up new approaches for treating metabolic diseases such as fatty liver disease.

  • Mylan receives SEC recommendation for import and marketing of Delanamid for MDR-TB

    Subject Expert committee of CDSCO recommends for grant of permission to import and market Delamanid Dispersible Tablets 25mg against pulmonary multi drug resistant tuberculosis (MDR-TB) in adults, adolescents, children and infants.

  • Indian Immunologicals to invest Rs 700 Crores to set up animal vaccine plant

    Indian Immunologicals Limited (IIL) announced that the company will invest about Rs 700 Crores to set up a new animal vaccine manufacturing facility in Genome Valley, Hyderabad.

    The IIL, a subsidiary of the National Dairy Development Board (NDDB), is already one of the world’s largest FMD vaccine manufacturers. It is also the leading vaccine supplier to the Government of India’s National Animal Disease Control Programme (NADCP).

  • Nanoscope Therapeutics Receives Fast Track Designation by the FDA for MCO-010 for the Treatment of Retinitis Pigmentosa

    Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to MCO-010, an ambient-light activatable Multi-Characteristic Opsin (MCO) optogenetic monotherapy to restore vision in blind patients, for the treatment of retinitis pigmentosa (RP) via intravitreal injection.

  • Panacea Biotech gets order of USD 127.30 million from UNICEF & PAHO for pentavalent vaccine

    Panacea Biotec, one of India's leading biotechnology companies, has received long-term supply awards worth USD 127.30 million (around INR 1,040 Crore) from UNICEF and Pan American Health Organization (PAHO) for supply of its WHO pre-qualified fully liquid Pentavalent vaccine, Easyfive-TT'" (DTwP-HepB-Hib).

  • Zinc could treat a rare genetic disorder

    Paediatric encephalopathies of genetic origin cause severe motor and intellectual disabilities from birth. One of these diseases, first identified in 2013, is caused by mutations in the GNAO1 gene. In order to understand the finer details of the resulting disturbances, scientists from the University of Geneva (UNIGE) conducted atomic, molecular and cellular analyses. They discovered that a mutation in GNAO1 leads to the replacement of one amino acid by another in protein sequence.

  • Celebrating 38th Foundation Day of IIHMR, Jaipur

    Indian Institute of Health Management Research (IIHMR) was established on 5 October 1984. To commemorate this special day IIHMR University celebrated its 38th Foundation Day on October 7, 2022.

    The event was graced by the benign presence of Chief Guest, Dr. Vishwa Mohan Katoch, President, JIPMER, Puducherry, Chairman, AIIMS, Madurai, Chairman LEPRA Society, Former Secretary, Department of Health Research, Government of India and Director General, Indian Council of Medical Research.

  • NPPA notified ceiling prices of cardiac stent remains same as earlier

    NPPA has received requests from few companies about trade margin clarification of cardiac stents. On which, NPPA notified that ceiling prices of cardiac stent remains same as earlier without any changes as notified on 30th March 2022 till further notice.

  • Detecting Alzheimer’s disease in the blood

    Researchers from Hokkaido University and Toppan have developed a method to detect build-up of amyloid β in the brain, a characteristic of Alzheimer’s disease, from biomarkers in blood samples.

Subscribe to Pharma News